Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 210639
Company: XIROMED
Company: XIROMED
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | 0.12% | AEROSOL, FOAM;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/18/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
BETAMETHASONE VALERATE
AEROSOL, FOAM;TOPICAL; 0.12%
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | 0.12% | AEROSOL, FOAM;TOPICAL | Prescription | No | AB | 078337 | PADAGIS ISRAEL |
BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | 0.12% | AEROSOL, FOAM;TOPICAL | Prescription | No | AB | 208204 | TARO |
BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | 0.12% | AEROSOL, FOAM;TOPICAL | Prescription | No | AB | 210639 | XIROMED |